Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Clascoterone 1% cream is a promising new treatment for acne.

Sarolaner effectively treats generalized demodicosis in dogs without side effects.

The treatment cleared psoriasis in some patients but caused side effects in most.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

CTP-543 is generally safe for treating alopecia areata.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Both treatment combinations improved hair growth similarly and were safe.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Erlotinib can cause excessive eyelash growth.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.